Clinical trial
Study of an Investigational Vaccine in Healthy Infants in Taiwan…
NCT00092469 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00092469 |
|---|---|
| Title | Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED) |
| Official title | A Registration Study of the Safety, Tolerability, and Immunogenicity of V441 in Healthy Infants in Taiwan |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis |
| Intervention type | Biological |
| Interventions | V441, diptheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant), & Haemophilus influenza type b conjugate vaccine |
| Enrollment | 151 |
| Start date | Mar 1, 2002 |
| Primary completion | Aug 1, 2003 |
| Completion | Aug 1, 2003 |
| First posted | Sep 27, 2004 |
| Last update posted | Oct 7, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: